Sign In
Buy NURO
$4.58
+0 (+0%)
At Close: Jul 30, 2025
NURO Stock: The ‘Breakthrough' News Rocketing NeuroMetrix Shares Higher Today
11:03am, Tuesday, 20'th Jul 2021
NeuroMetrix (NURO) stock is surging higher on Tuesday after getting "Breakthrough Device Designation" from the FDA for Quell. The post NURO Stock: The ‘Breakthrough' News Rocketing NeuroMetrix Share
NeuroMetrix's Nerve Stimulator Shows Mixed Outcomes In Fibromyalgia Trial
11:20am, Wednesday, 09'th Jun 2021
NeuroMetrix Inc (NASDAQ: NURO) has reported that top-line results from a randomized controlled trial of Quell for fibromyalgia will be presented at two upcoming pain medicine conferences. Quell is
NeuroMetrix, Inc.'s (NURO) CEO Shai Gozani on Q1 2021 Results - Earnings Call Transcript
10:43am, Thursday, 22'nd Apr 2021
NeuroMetrix, Inc.'s (NURO) CEO Shai Gozani on Q1 2021 Results - Earnings Call Transcript
NeuroMetrix, Inc. Announces Date for First Quarter 2021 Financial Results Conference Call
01:00pm, Thursday, 15'th Apr 2021
WOBURN, Mass., April 15, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2021 first quarter financial results before the opening of the market on A
NeuroMetrix, Inc. (NURO) CEO Dr. Shai Gozani on Q4 2020 Results - Earnings Call Transcript
08:46pm, Thursday, 28'th Jan 2021
NeuroMetrix, Inc. (NURO) CEO Dr. Shai Gozani on Q4 2020 Results - Earnings Call Transcript
NeuroMetrix Reports Q4 and Full Year 2020 Financial Results
07:00am, Thursday, 28'th Jan 2021
WOBURN, Mass., Jan. 28, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter and year ended December 31, 2020. The Company is focu
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2020 Financial Results Conference Call
11:05am, Friday, 22'nd Jan 2021
WOBURN, Mass., Jan. 22, 2021 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2020 fourth quarter and full year financial results before the opening of t
Why NeuroMetrix's Stock is Up During Today's Session
01:38pm, Tuesday, 08'th Dec 2020
NeuroMetrix (NASDAQ: NURO) is currently up 45.17% to a price of $3.04. The stock's volume is currently 62.04 million, which is roughly 32668.92% of its recent 30-day volume average of 189.91 thousand.
NURO Stock: 10 Things for Potential Investors to Know About NeuroMetrix
12:13pm, Tuesday, 08'th Dec 2020
NeuroMetrix (NURO) stock is on the rise Tuesday with heavy trading despite a lack of news concerning the medical device company. The post NURO Stock: 10 Things for Potential Investors to Know About Ne
Brokerages Expect Sensus Healthcare Inc (NASDAQ:SRTS) to Announce -$0.13 EPS
07:52am, Tuesday, 13'th Oct 2020
Equities analysts forecast that Sensus Healthcare Inc (NASDAQ:SRTS) will announce ($0.13) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Three analysts hav
Keloid Treatment Market Analytical Overview, Growth Factors, Demand, Trends and Forecast to 2025
04:34am, Wednesday, 07'th Oct 2020
Oct 07, 2020 (Heraldkeepers) --
Global Keloid Treatment Market share consists of several players including Pacific World Corporation, Revitol Corporation...
Smart Medical Devices Market 2020 Global Share, Trend, Segmentation, Analysis and Forecast to 2026
10:07pm, Friday, 25'th Sep 2020
Sep 25, 2020 (AB Digital via COMTEX) --
Smart Medical Devices Market 2020 A new report added to the online inventory of Wise Guys Reports (WGR) reveals that...
NeuroMetrix Announces Issuance of New U.S. Patent for Quell® Wearable Technology
05:00pm, Monday, 21'st Sep 2020
NeuroMetrix, Inc. (Nasdaq: NURO) announced today that the U.S. Patent and Trademark Office will issue on September 22, 2020 U.S. Patent No. 10,780,269 titled
Quell® Fills Unmet Need for Chronic Knee Pain Relief that is Drug-Free
02:00pm, Monday, 10'th Aug 2020
WOBURN, Mass., Aug. 10, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) published an infographic on chronic knee pain (available here) and provided an update on how Quell technology address
NeuroMetrix Reports Q2 2020 Financial Results
11:00am, Thursday, 23'rd Jul 2020
WOBURN, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended June 30, 2020. The Company is a leading develop
